Our current findings demonstrate an important role of the cGAS-STING signaling pathway in mediating the detrimental consequences including proteinuria and glomerular dysfunction and point to STING as a potential therapeutic target in glomerular diseases of metabolic and non-metabolic origin (37). This evidence concerns the gene STING1 and glomerular disorder.